BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20876405)

  • 1. No beneficial effects of pine bark extract on cardiovascular disease risk factors.
    Drieling RL; Gardner CD; Ma J; Ahn DK; Stafford RS
    Arch Intern Med; 2010 Sep; 170(17):1541-7. PubMed ID: 20876405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study on the clinical effects of dietary supplementation with Enzogenol, a flavonoid extract of pine bark and vitamin C.
    Shand B; Strey C; Scott R; Morrison Z; Gieseg S
    Phytother Res; 2003 May; 17(5):490-4. PubMed ID: 12748985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low molecular weight procyanidin rich extract from french maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-blind, crossover, placebo-controlled intervention trial.
    Valls RM; Llauradó E; Fernández-Castillejo S; Puiggrós F; Solà R; Arola L; Pedret A
    Phytomedicine; 2016 Nov; 23(12):1451-1461. PubMed ID: 27765365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract.
    Maimoona A; Naeem I; Saddiqe Z; Jameel K
    J Ethnopharmacol; 2011 Jan; 133(2):261-77. PubMed ID: 21044675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication.
    Chayasirisobhon S
    Headache; 2006 May; 46(5):788-93. PubMed ID: 16643582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
    Biegert C; Wagner I; Lüdtke R; Kötter I; Lohmüller C; Günaydin I; Taxis K; Heide L
    J Rheumatol; 2004 Nov; 31(11):2121-30. PubMed ID: 15517622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans.
    Nishioka K; Hidaka T; Nakamura S; Umemura T; Jitsuiki D; Soga J; Goto C; Chayama K; Yoshizumi M; Higashi Y
    Hypertens Res; 2007 Sep; 30(9):775-80. PubMed ID: 18037769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholesterolaemic rabbits.
    Shukla R; Gupta S; Gambhir JK; Prabhu KM; Murthy PS
    J Ethnopharmacol; 2004 May; 92(1):47-51. PubMed ID: 15099846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract formulation.
    Pipingas A; Silberstein RB; Vitetta L; Rooy CV; Harris EV; Young JM; Frampton CM; Sali A; Nastasi J
    Phytother Res; 2008 Sep; 22(9):1168-74. PubMed ID: 18683195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year.
    Jorde R; Sneve M; Torjesen P; Figenschau Y
    J Intern Med; 2010 May; 267(5):462-72. PubMed ID: 20141565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
    James WP; Caterson ID; Coutinho W; Finer N; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Shepherd GM; Rode RA; Renz CL;
    N Engl J Med; 2010 Sep; 363(10):905-17. PubMed ID: 20818901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional management of cardiovascular risk factors. A randomized clinical trial.
    McCarron DA; Oparil S; Chait A; Haynes RB; Kris-Etherton P; Stern JS; Resnick LM; Clark S; Morris CD; Hatton DC; Metz JA; McMahon M; Holcomb S; Snyder GW; Pi-Sunyer FX
    Arch Intern Med; 1997 Jan; 157(2):169-77. PubMed ID: 9009974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.
    Nagao T; Hase T; Tokimitsu I
    Obesity (Silver Spring); 2007 Jun; 15(6):1473-83. PubMed ID: 17557985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women.
    Wu JH; Hodgson JM; Puddey IB; Belski R; Burke V; Croft KD
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):774-80. PubMed ID: 19346113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.
    Ramel A; Pumberger C; Martinéz AJ; Kiely M; Bandarra NM; Thorsdottir I
    Nutr Res; 2009 May; 29(5):305-12. PubMed ID: 19555811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
    Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
    Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.